Tag: ALK Inhibitors

Home / ALK Inhibitors

Categories

Ensartinib is approved by the USFDA for ALK-positive locally advanced or metastatic non-small cell lung cancer

 On December 18, 2024, the Food and Drug Administration sanctioned ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or ...
alk-inhibitors

Scan the code